Next generation medicinesLearn more We design and develop drugs based on a novel therapeutic approach called melitherapy.A new pharmaceutical perspectiveLearn more Our drugs are first-in-class molecules which target membrane lipids, instead of acting directly on proteins or DNA like other medicines. Committed to peopleLearn more Our goal is to deliver reference treatments for illnesses with unmet medical needs, such as cancer and Alzheimer’s disease.
New seek capital round open, contact with inversores@laminarpharma.com in case of interest
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.AcceptRejectRead More
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.